Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1990 Dec;53(12):1063–1067. doi: 10.1136/jnnp.53.12.1063

Neuronal ceroid-lipofuscinosis: preferential metabolic alterations in thalamus and posterior association cortex demonstrated by PET.

A G De Volder 1, S Cirelli 1, T de Barsy 1, J M Brucher 1, A Bol 1, C Michel 1, A M Goffinet 1
PMCID: PMC488316  PMID: 2292699

Abstract

Regional brain glucose utilisation was investigated with positron emission tomography (PET) and fluorodeoxyglucose (FDG) in four siblings with neuronal ceroid-lipofuscinosis. A consistent pattern was found, namely a decrease of glucose utilisation in all grey structures but more marked at the level of the thalamus and posterior association cortex. The severity of metabolic anomalies was correlated with the degree of clinical impairment and with disease duration; they were the most severe in the oldest patient, who was also the most affected clinically, intermediate in two others, and minimal in the subject with the shortest period of development of the disease. These observations suggest that PET is useful for the definition of anatomical targets of metabolic diseases and for the investigation of their pathophysiology.

Full text

PDF
1063

Images in this article

1065Image
on p.1065

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baron J. C., D'Antona R., Pantano P., Serdaru M., Samson Y., Bousser M. G. Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man. Brain. 1986 Dec;109(Pt 6):1243–1259. doi: 10.1093/brain/109.6.1243. [DOI] [PubMed] [Google Scholar]
  2. Berkovic S. F., Carpenter S., Andermann F., Andermann E., Wolfe L. S. Kufs' disease: a critical reappraisal. Brain. 1988 Feb;111(Pt 1):27–62. doi: 10.1093/brain/111.1.27. [DOI] [PubMed] [Google Scholar]
  3. Boustany R. M., Kolodny E. H. Neurological progress. The neuronal ceroid lipofuscinoses: a review. Rev Neurol (Paris) 1989;145(2):105–110. [PubMed] [Google Scholar]
  4. Carlier G., Dubru J. M. Familial juvenile Parkinsonism. Acta Paediatr Belg. 1979 Apr-Jun;32(2):123–127. [PubMed] [Google Scholar]
  5. De Volder A. G., Francart J., Laterre C., Dooms G., Bol A., Michel C., Goffinet A. M. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration. Ann Neurol. 1989 Aug;26(2):239–247. doi: 10.1002/ana.410260210. [DOI] [PubMed] [Google Scholar]
  6. De Volder A. G., Jaeken J., Van den Berghe G., Bol A., Michel C., Cogneau M., Goffinet A. M. Regional brain glucose utilization in adenylosuccinase-deficient patients measured by positron emission tomography. Pediatr Res. 1988 Aug;24(2):238–242. doi: 10.1203/00006450-198808000-00020. [DOI] [PubMed] [Google Scholar]
  7. DeVolder A. G., Goffinet A. M., Bol A., Michel C., de Barsy T., Laterre C. Brain glucose metabolism in postanoxic syndrome. Positron emission tomographic study. Arch Neurol. 1990 Feb;47(2):197–204. doi: 10.1001/archneur.1990.00530020103022. [DOI] [PubMed] [Google Scholar]
  8. Gibb W. R., Luthert P. J., Marsden C. D. Corticobasal degeneration. Brain. 1989 Oct;112(Pt 5):1171–1192. doi: 10.1093/brain/112.5.1171. [DOI] [PubMed] [Google Scholar]
  9. Gjedde A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res. 1982 Jun;257(2):237–274. doi: 10.1016/0165-0173(82)90018-2. [DOI] [PubMed] [Google Scholar]
  10. Goffinet A. M., De Volder A. G., Gillain C., Rectem D., Bol A., Michel C., Cogneau M., Labar D., Laterre C. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy. Ann Neurol. 1989 Feb;25(2):131–139. doi: 10.1002/ana.410250205. [DOI] [PubMed] [Google Scholar]
  11. Greenwood R. S., Nelson J. S. Atypical neuronal ceroid-lipofuscinosis. Neurology. 1978 Jul;28(7):710–717. doi: 10.1212/wnl.28.7.710. [DOI] [PubMed] [Google Scholar]
  12. Heiss W. D., Hebold I., Klinkhammer P., Ziffling P., Szelies B., Pawlik G., Herholz K. Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography. J Cereb Blood Flow Metab. 1988 Aug;8(4):613–617. doi: 10.1038/jcbfm.1988.104. [DOI] [PubMed] [Google Scholar]
  13. Kohlschütter A., Laabs R., Albani M. Juvenile neuronal ceroid lipofuscinosis (JNCL): quantitative description of its clinical variability. Acta Paediatr Scand. 1988 Nov;77(6):867–872. doi: 10.1111/j.1651-2227.1988.tb10770.x. [DOI] [PubMed] [Google Scholar]
  14. Tobo M., Mitsuyama Y., Ikari K., Itoi K. Familial occurrence of adult-type neuronal ceroid lipofuscinosis. Arch Neurol. 1984 Oct;41(10):1091–1094. doi: 10.1001/archneur.1984.04050210089022. [DOI] [PubMed] [Google Scholar]
  15. Tomé F. M., Brunet P., Fardeau M., Hentati F., Reix J. Familial disorder of the central and peripheral nervous systems with particular cytoplasmic lamellated inclusions in peripheral nerves, muscle satellite cells, and blood capillaries. Acta Neuropathol. 1985;68(3):209–217. doi: 10.1007/BF00690197. [DOI] [PubMed] [Google Scholar]
  16. Volkow N. D., Patchell L., Kulkarni M. V., Reed K., Simmons M. Adrenoleukodystrophy: imaging with CT, MRI, and PET. J Nucl Med. 1987 Apr;28(4):524–527. [PubMed] [Google Scholar]
  17. Yanai K., Iinuma K., Matsuzawa T., Ito M., Miyabayashi S., Narisawa K., Ido T., Yamada K., Tada K. Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography. Eur J Nucl Med. 1987;13(6):292–296. doi: 10.1007/BF00256553. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES